← Research hub  ·  securities

CRNX · Crinetics Pharmaceuticals $84.95 +0.00 (+0.00%) 2026-AUG-31 16:00 EST

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA1 mention
2026-AUG-16 · Jay Singh · Weekly SSR research call (premium) · Positivemention · source page ↗$84.38

In short: A regulatory leg retired: "CRNX also received Austrian anti-trust approval overnight."

Full passage: premium transcript (PDF).

SOD $84.38 (open 2026-AUG-14)

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.